Esketamine Nasal Spray Improves Rate and Time to Remission Versus Quetiapine Extended Release in Subgroups of Patients With Treatment Resistant Depression and Two or Three Plus Pri...

por Young, A.H., Cubała, W.J., Nielsen, R.E., Popova, A., Ito, T., Mulhern-Haughey, S., Pirotte, N., Rive, B., Thilakarathne, P., Usankova, I., Godinov, Y.
Publicado 2023